The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I, randomized, controlled, multicentre trial of isolated hepatic perfusion in combination with ipilimumab and nivolumab in patients with uveal melanoma metastases (the SCANDIUM 2 trial).
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics; Skyline Diagnostics (Inst)
 
Axel Nelson
No Relationships to Disclose
 
Amir Shafazand
Employment - AstraZeneca (I); WorldCare Clinical, LLC
 
Christian Cahlin
Stock and Other Ownership Interests - Hansa Biopharma; Hansa Biopharma (I); Isofol Medical; Isofol Medical (I)
 
Ana Carneiro
Honoraria - BMSi
Consulting or Advisory Role - Baxter; Merck (Inst); MSD; Novartis; Pierre Fabre; Transgene (Inst)
Expert Testimony - BMSi; Merck
 
Hildur Helgadottir
No Relationships to Disclose
 
Max Levin
No Relationships to Disclose
 
Magnus Rizell
No Relationships to Disclose
 
Gustav J. Ullenhag
Stock and Other Ownership Interests - Essity
Honoraria - Bristol-Myers Squibb/Medarex; MSD Oncology; Novartis; Pierre Fabre
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb/Medarex; Incyte; LIDDS; MSD Oncology; Novartis; Sanofi; SeqCure Immunology
Research Funding - Alligator Bioscience; Lokon Pharma
 
Sara Wirén
No Relationships to Disclose
 
Per Lindner
No Relationships to Disclose
 
Jonas A Nilsson
No Relationships to Disclose
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; LEO Pharma; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)